27405 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 27
14:44 UTC
|
VEEV
Veeva Systems
|
◎ Target | Tamjid Chowdhury not yet tracked | Buy | $276.00→ $310.00+12.3% |
|
Aug 27
14:44 UTC
|
URBN
Urban Outfitters
|
◎ Target | Ike Boruchow ★★★☆☆ #2216 | Equal Weight | $75.00→ $80.00+6.7% |
|
Aug 27
14:44 UTC
|
STXS
Stereotaxis
|
◎ Target | Daniel Stauder not yet tracked | Market Outperform | $4.00→ $3.00-25.0% |
|
Aug 27
14:44 UTC
|
SJM
J. M. Smucker
|
◎ Target | Chris Carey not yet tracked | Overweight | $129.00→ $144.00+11.6% |
|
Aug 27
14:44 UTC
|
P
Everpure
|
◎ Target | Aaron Rakers ★★★★★ #291 | Overweight | $97.00→ $135.00+39.2% |
|
Aug 27
14:44 UTC
|
OWL
Blue Owl Capital
|
◎ Target | Chris Kotowski ★★★★☆ #692 | Outperform | $15.00→ $17.00+13.3% |
|
Aug 27
14:44 UTC
|
OKTA
Okta
|
◎ Target | Keith Bachman ★★★★★ #250 | Outperform | $168.00→ $187.00+11.3% |
|
Aug 27
14:44 UTC
|
OKTA
Okta
|
◎ Target | Rustam Kanga not yet tracked | Market Outperform | $170.00→ $180.00+5.9% |
|
Aug 27
14:44 UTC
|
NTNX
Nutanix
|
◎ Target | Param Singh ★★★★☆ #388 | Outperform | $80.00→ $85.00+6.2% |
|
Aug 27
14:44 UTC
|
NTNX
Nutanix
|
◎ Target | Aaron Rakers ★★★★★ #291 | Equal Weight | $55.00→ $65.00+18.2% |
|
Aug 27
14:44 UTC
|
KYMR
Kymera Therapeutics
|
◎ Target | Derek Archila ★★☆☆☆ #2402 | Overweight | $116.00→ $151.00+30.2% |
|
Aug 27
14:44 UTC
|
KKR
KKR & Co. Inc.
|
◎ Target | Chris Kotowski ★★★★☆ #692 | Outperform | $139.00→ $166.00+19.4% |
|
Aug 27
14:44 UTC
|
HLNE
Hamilton Lane
|
◎ Target | Chris Kotowski ★★★★☆ #692 | Outperform | $182.00→ $181.00-0.5% |
|
Aug 27
14:44 UTC
|
GWRE
Guidewire Software
|
◎ Target | Tamjid Chowdhury not yet tracked | Buy | $180.00→ $210.00+16.7% |
|
Aug 27
14:44 UTC
|
DY
Dycom Industries
|
◎ Target | Eric Luebchow ★★☆☆☆ #2407 | Overweight | $650.00→ $550.00-15.4% |
|
Aug 27
14:44 UTC
|
CRM
Salesforce
|
◎ Target | Michael Turrin ★★★☆☆ #1000 | Equal Weight | $205.00→ $230.00+12.2% |
|
Aug 27
14:44 UTC
|
CRM
Salesforce
|
◎ Target | Karl Keirstead ★★★★☆ #471 | Neutral | $210.00→ $240.00+14.3% |
|
Aug 27
14:44 UTC
|
CRM
Salesforce
|
◎ Target | Keith Bachman ★★★★★ #250 | Outperform | $230.00→ $260.00+13.0% |
|
Aug 27
14:44 UTC
|
BX
Blackstone
|
◎ Target | Christopher Kotowski not yet tracked | Outperform | $140.00→ $171.00+22.1% |
|
Aug 27
14:44 UTC
|
BRZE
Braze
|
◎ Target | Brian Schwartz ★★☆☆☆ #2354 | Outperform | $30.00→ $36.00+20.0% |
|
Aug 27
14:44 UTC
|
BBWI
Bath & Body Works
|
◎ Target | Ike Boruchow ★★★☆☆ #2216 | Overweight | $26.00→ $24.00-7.7% |
|
Aug 27
14:44 UTC
|
ARES
Ares Management
|
◎ Target | Chris Kotowski ★★★★☆ #692 | Outperform | $151.00→ $162.00+7.3% |
|
Aug 27
14:44 UTC
|
AMLX
Amylyx Pharmaceuticals
|
◎ Target | Seamus Fernandez ★★★☆☆ #1385 | Buy | $55.00→ $57.00+3.6% |
|
Aug 27
13:44 UTC
|
WSM
Williams-Sonoma
|
◎ Target | Simeon Gutman ★★★☆☆ #1725 | Equal Weight | $210.00→ $240.00+14.3% |
|
Aug 27
13:44 UTC
|
VSXY
Victoria's Secret & Co.
|
◎ Target | Dana Telsey ★★☆☆☆ #2255 | Outperform | $90.00→ $100.00+11.1% |
|
Aug 27
13:44 UTC
|
VEEV
Veeva Systems
|
◎ Target | Jailendra Singh ★★★★☆ #353 | Buy | $262.00→ $305.00+16.4% |
|
Aug 27
13:44 UTC
|
VEEV
Veeva Systems
|
◎ Target | Craig Hettenbach ★★★★☆ #348 | Equal Weight | $215.00→ $275.00+27.9% |
|
Aug 27
13:44 UTC
|
SW
Smurfit Westrock
|
◎ Target | Brian Morton ★★★★☆ #608 | Overweight | $57.00→ $58.00+1.8% |
|
Aug 27
13:44 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Gregory Renza ★★★☆☆ #1442 | Buy | $231.00→ $239.00+3.5% |
|
Aug 27
13:44 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Robert Driscoll ★★★★☆ #676 | Outperform | $201.00→ $225.00+11.9% |
|
Aug 27
13:44 UTC
|
P
Everpure
|
◎ Target | Benjamin Swinburne ★★★☆☆ #2015 | Overweight | $108.00→ $119.00+10.2% |
|
Aug 27
13:44 UTC
|
P
Everpure
|
◎ Target | Matt Bryson ★★★★★ #119 | Outperform | $127.00→ $130.00+2.4% |
|
Aug 27
13:44 UTC
|
OKTA
Okta
|
◎ Target | Rudy Kessinger ★★★★★ #73 | Buy | $165.00→ $190.00+15.2% |
|
Aug 27
13:44 UTC
|
OKTA
Okta
|
◎ Target | Eric Heath ★★★★★ #13 | Overweight | $180.00→ $190.00+5.6% |
|
Aug 27
13:44 UTC
|
OKTA
Okta
|
◎ Target | Simeon Gutman ★★★☆☆ #1725 | Overweight | $180.00→ $200.00+11.1% |
|
Aug 27
13:44 UTC
|
NVDA
NVIDIA
|
◎ Target | Matt Bryson ★★★★★ #119 | Outperform | $330.00→ $345.00+4.5% |
|
Aug 27
13:44 UTC
|
NVDA
NVIDIA
|
◎ Target | William Stein ★★☆☆☆ #2239 | Buy | $307.00→ $346.00+12.7% |
|
Aug 27
13:44 UTC
|
NTNX
Nutanix
|
◎ Target | Meta Marshall ★★★★☆ #461 | Equal Weight | $55.00→ $63.00+14.5% |
|
Aug 27
13:44 UTC
|
META
Meta Platforms
|
◎ Target | Youssef Squali ★★★☆☆ #1351 | Buy | $770.00→ $763.00-0.9% |
|
Aug 27
13:44 UTC
|
META
Meta Platforms
|
◎ Target | Barton Crockett ★★★★☆ #677 | Buy | $883.00→ $886.00+0.3% |
|
Aug 27
13:44 UTC
|
KSS
Kohl's
|
◎ Target | Dana Telsey ★★☆☆☆ #2255 | Market Perform | $17.00→ $18.00+5.9% |
|
Aug 27
13:44 UTC
|
IRM
Iron Mountain
|
◎ Target | Tobey Sommer ★★★★☆ #470 | Buy | $140.00→ $155.00+10.7% |
|
Aug 27
13:44 UTC
|
FOUR
Shift4 Payments
|
◎ Target | Matthew Coad ★★★★☆ #464 | Hold | $50.00→ $49.00-2.0% |
|
Aug 27
13:44 UTC
|
DY
Dycom Industries
|
◎ Target | Sangita Jain ★★☆☆☆ #2408 | Overweight | $610.00→ $423.00-30.7% |
|
Aug 27
13:44 UTC
|
DRI
Darden Restaurants
|
◎ Target | Christopher Carril ★☆☆☆☆ #2872 | Overweight | $228.00→ $237.00+3.9% |
|
Aug 27
13:44 UTC
|
DLO
DLocal
|
◎ Target | Matthew Coad ★★★★☆ #464 | Buy | $17.00→ $18.00+5.9% |
|
Aug 27
13:44 UTC
|
DEA
Easterly Government Properties
|
◎ Target | Michael Lewis ★★★☆☆ #1685 | Hold | $24.00→ $26.00+8.3% |
|
Aug 27
13:44 UTC
|
CSN
Chesnara
|
◎ Target | firm only | Outperform | GBX 360→ GBX 400+11.1% |
|
Aug 27
13:44 UTC
|
CRM
Salesforce
|
◎ Target | Keith Weiss ★★★★☆ #694 | Equal Weight | $185.00→ $235.00+27.0% |
|
Aug 27
13:44 UTC
|
CRM
Salesforce
|
◎ Target | Gil Luria ★★★☆☆ #1463 | Neutral | $175.00→ $200.00+14.3% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.